Activation of tumor-cell STING primes NK-cell therapy

EH Knelson, EV Ivanova, M Tarannum… - Cancer immunology …, 2022 - AACR
Activation of the stimulator of interferon genes (STING) pathway promotes antitumor
immunity but STING agonists have yet to achieve clinical success. Increased understanding …
被引用次数：30 相关文章
[HTML] nih.gov

[HTML][HTML] Activation of tumor-cell STING primes NK-cell therapy

EH Knelson, EV Ivanova, M Tarannum… - Cancer immunology …, 2022 - ncbi.nlm.nih.gov
Activation of the stimulator of interferon genes (STING) pathway promotes antitumor
immunity but STING agonists have yet to achieve clinical success. Increased understanding …

Activation of Tumor-Cell STING Primes NK-Cell Therapy

EH Knelson, EV Ivanova, M Tarannum… - Cancer Immunology …, 2022 - AACR
Activation of the stimulator of interferon genes (STING) pathway promotes antitumor
immunity but STING agonists have yet to achieve clinical success. Increased understanding …

Activation of Tumor-Cell STING Primes NK-Cell Therapy

EH Knelson, EV Ivanova… - Cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
Activation of the stimulator of interferon genes (STING) pathway promotes antitumor
immunity but STING agonists have yet to achieve clinical success. Increased understanding …

Activation of Tumor-Cell STING Primes NK-Cell Therapy

EH Knelson, EV Ivanova, M Tarannum… - Cancer Immunology …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title/>< jats: p> Activation of the
stimulator of interferon genes (STING) pathway promotes antitumor immunity but STING …

Activation of Tumor-Cell STING Primes NK-Cell Therapy.

EH Knelson, EV Ivanova, M Tarannum… - Cancer Immunology …, 2022 - europepmc.org
Activation of the stimulator of interferon genes (STING) pathway promotes antitumor
immunity but STING agonists have yet to achieve clinical success. Increased understanding …